Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

<p>SPINZ total costs by study period.</p>

Domain:

healthcare

Record type:

dataset
Creator:
LorRebSusSyl
Host:avatar

The Sepsis Prevention in Neonates in Zambia (SPINZ) trial was a prospective observational cohort study conducted in the neonatal intensive care unit of the University Teaching Hospital in Lusaka, Zambia. Introduction of an infection prevention and control (IPC) bundle reduced hospital-associated mortality, total mortality, suspected sepsis, and confirmed bloodstream infections. This companion analysis was undertaken to analyze intervention costs and cost-effectiveness in this low-resource setting. We conducted a retrospective cost analysis, using SPINZ study-related records, and expressed costs in real 2016 US dollars. We also estimated intervention cost-effectiveness using both outcomes from SPINZ (avoided deaths, confirmed bloodstream infections, and suspected episodes of infection) and estimated disability-adjusted life years (DALYs) averted by the intervention. To provide data for policymakers, a future cost projection was undertaken to estimate costs of the program implemented nationally over a 10-year period in real 2025 US dollars. A total of 2,035 neonates were enrolled from September 2015 to March 2017. Total costs during implementation (introduction of the IPC bundle) (April-May 2016) and the subsequent intervention period were $17,641 and $5,265, respectively, of which most expenses were incurred during the preparation period due to travel and training. During the intervention period, the program’s running cost was approximately $478 per month. The estimated cost per death, confirmed infection, and suspected episode averted was $208, $204, and $32, respectively; the estimated cost per DALY averted was $7. The future model was estimated to cost an average of $107,561 annually to implement nationally. The analysis indicated that the IPC bundle to prevent sepsis-related neonatal mortality was highly cost-effective. Cost reductions from task-shifting, reduced preparation (start-up) costs, and longer intervention periods would further decrease cost per death averted. IPC bundle implementation can thus be recommended for resource-constrained settings where sepsis and other nosocomial infections are associated with high neonatal mortality.

Visit

figshare.com

Tags

MedicineNeuroscienceScience PolicyInfectious Diseasesuniversity teaching hospitalprogram &# 8217adjusted life years478 per monthprogram implemented nationallyconfirmed bloodstream infections+37

Licenses

CC BY 4.0

Similar

<p>Monitoring costs by item.</p><p>Cross-cutting costs.</p><p>Predictors of Total Number of Infections.</p><p>Testing scenario costs per patient (2024 USD).</p><p>Performance by subgroup.</p><p>Missingness by variable.</p>

<p>Monitoring costs by item.</p>

As programs for azithromycin mass drug administration (AZ-MDA) to reduce child mortality hav

<p>Cross-cutting costs.</p>

As programs for azithromycin mass drug administration (AZ-MDA) to reduce child mortality hav

<p>Predictors of Total Number of Infections.</p>

Background

Worldwide, 451 million people and up to 156 million children are infected

<p>Testing scenario costs per patient (2024 USD).</p>

South Africa has high sexually transmitted infections (STIs) prevalence and currently implem

<p>Performance by subgroup.</p>

Background

Humanitarian settings are highly vulnerable to infectious disease outbreaks

<p>Missingness by variable.</p>

Introduction

Cryptococcal meningitis remains a leading cause of HIV-related mortality